Cargando…
Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers
BACKGROUND: The impact of an inherited BRCA2 mutation on the prognosis of women with breast cancer has not been well documented. We studied the effects of oestrogen receptor (ER) status, other prognostic factors and treatments on survival in a large cohort of BRCA2 mutation carriers. METHODS: We ide...
Autores principales: | Jonasson, Jon G, Stefansson, Olafur A, Johannsson, Oskar T, Sigurdsson, Helgi, Agnarsson, Bjarni A, Olafsdottir, Gudridur H, Alexiusdottir, Kristin K, Stefansdottir, Hrefna, Munoz Mitev, Rodrigo, Olafsdottir, Katrin, Olafsdottir, Kristrun, Arason, Adalgeir, Stefansdottir, Vigdis, Olafsdottir, Elinborg J, Barkardottir, Rosa B, Eyfjord, Jorunn E, Narod, Steven A, Tryggvadóttir, Laufey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046206/ https://www.ncbi.nlm.nih.gov/pubmed/27537391 http://dx.doi.org/10.1038/bjc.2016.249 |
Ejemplares similares
-
CpG island hypermethylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer
por: Stefansson, Olafur Andri, et al.
Publicado: (2011) -
BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy
por: Stefansson, Olafur A, et al.
Publicado: (2019) -
BRCA2 mutation carriers, reproductive factors and breast cancer risk
por: Tryggvadottir, Laufey, et al.
Publicado: (2003) -
In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to Sweden
por: Agustsson, Arnar S., et al.
Publicado: (2020) -
High expression of the vacuole membrane protein 1 (VMP1) is a potential marker of poor prognosis in HER2 positive breast cancer
por: Amirfallah, Arsalan, et al.
Publicado: (2019)